Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.39 |
| ▸ | RPS6KA5 | O75582 | 1/20 | 0.37 |
| ▸ | RORC | P51449 | 1/20 | 0.33 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.32 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.31 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.31 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.31 |
| ▸ | LCK | P06239 | 1/20 | 0.31 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21453321 | 0.87 | FFAR4 (0.36) | RORCMAPK14 | |
| SCHEMBL21453322 | 0.85 | RORC (0.34) | RORCMAPK14 | |
| SCHEMBL21453324 | 0.83 | RORC (0.36) | RORC | |
| SCHEMBL21453320 | 0.83 | RORC (0.33) | RORC | |
| SCHEMBL21453326 | 0.81 | CYP1A2 (0.41) | RORCMAPK14 | |
| SCHEMBL17993426 | 0.68 | PTGDR2 (0.56) | PTGDR2RPS6KA5CYP17A1MKNK1MKNK2 | |
| SCHEMBL21453571 | 0.68 | PTGDR2 (0.35) | PTGDR2RPS6KA5 | |
| SCHEMBL21453318 | 0.67 | CYP1A2 (0.41) | MAPK14 | |
| SCHEMBL19864888 | 0.67 | RORC (0.35) | RORCMKNK1MKNK2MAPK14 | |
| SCHEMBL19862095 | 0.66 | ALDH1A1 (0.40) | MAPK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190312210-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-10-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190312210-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SLCO4C1, SLCO2A1, SLCO1A2 | PTGDR2 3487/4885RPS6KA5 3905/4885RORC 3456/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.